PARTNERS

We have partnered with Merck to advance an allogeneic cell therapy program. We are honored to be Merck’s first partner in the cell therapy area, a validation of our Tmod™ platform. Learn More

We partnered with Tempus AI, a leader in genetic diagnostic testing, artificial intelligence and precision medicine, to develop a companion diagnostic to identify those patients whose tumors have lost HLA-A*02. This diagnostic technology can also be used to support the development of further diagnostic testing for future programs. Learn More